Literature DB >> 26166864

Synthesis and RP HPLC studies of biologically active semicarbazides and their cyclic analogues 1,2,4-triazol-3-ones.

Monika Pitucha1, Joanna Matysiak2, Bogdan Senczyna2.   

Abstract

ABSTRACT: The retention behaviour of semicarbazides and their cyclic analogues 1,2,4-triazol-3-ones, has been investigated by RP-8, RP-18 and IAM HPLC. The structures of new derivatives were proved by elemental analyses, IR, 1H NMR and 13C NMR spectroscopy. The compounds showed regular retention behaviour in three chromatographic systems; their log k values decreased linearly with the increasing concentration of an organic modifier in the mobile phase. The ratio of the intercept (log kw) to the slope of compounds is constant and the same for both groups of compounds on C18 and IAM stationary phases. Differences between log kw values from the octadecyl stationary phase of corresponding cyclic and linear derivatives are constant, and they are related to the mechanism of synthesis of 1,2,4-triazol-3-ones from linear substrate semicarbazides, which was confirmed by modelling studies. Good correlations between log kw parameters obtained by RP-8 or RP-18 and determined by the computational approach log P were found.

Entities:  

Keywords:  1,2,4-Triazol-3-one; IAM chromatography; Lipophilicity; RP HPLC; Semicarbazide

Year:  2012        PMID: 26166864      PMCID: PMC4495053          DOI: 10.1007/s00706-011-0715-z

Source DB:  PubMed          Journal:  Monatsh Chem        ISSN: 0026-9247            Impact factor:   1.451


  19 in total

1.  Synthesis and in-vitro antimicrobial activity of new 1,2,4-triazoles.

Authors:  A R Bhat; G V Bhat; G G Shenoy
Journal:  J Pharm Pharmacol       Date:  2001-02       Impact factor: 3.765

2.  Applications of immobilised artificial membrane chromatography to quaternary alkylammonium sulfobetaines and comparison of chromatographic methods for estimating the octanol-water partition coefficient.

Authors:  Robert S Ward; Joanna Davies; Geoffrey Hodges; David W Roberts
Journal:  J Chromatogr A       Date:  2003-07-25       Impact factor: 4.759

3.  Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides.

Authors:  J T Witkowski; R K Robins; R W Sidwell; L N Simon
Journal:  J Med Chem       Date:  1972-11       Impact factor: 7.446

4.  Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions.

Authors:  A K Ghose; G M Crippen
Journal:  J Chem Inf Comput Sci       Date:  1987-02

5.  Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces.

Authors:  S Ong; H Liu; X Qiu; G Bhat; C Pidgeon
Journal:  Anal Chem       Date:  1995-02-15       Impact factor: 6.986

6.  Synthesis and antibacterial activities of some 4,5-dihydro-1H-1,2,4-triazol-5-ones.

Authors:  H Yüksek; A Demirbaş; A Ikizler; C B Johansson; C Celik; A A Ikizler
Journal:  Arzneimittelforschung       Date:  1997-04

7.  In vitro inhibition properties of a new group of thiobenzanilides in relation to yeasts.

Authors:  J Matysiak; A Niewiadomy; G Macik-Niewiadomy
Journal:  Eur J Pharm Sci       Date:  2000-04       Impact factor: 4.384

8.  Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.

Authors:  Nilkanth G Aher; Vandana S Pore; Nripendra N Mishra; Awanit Kumar; Praveen K Shukla; Aanchal Sharma; Manoj K Bhat
Journal:  Bioorg Med Chem Lett       Date:  2008-12-10       Impact factor: 2.823

Review 9.  Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution.

Authors:  Klára Valkó
Journal:  J Chromatogr A       Date:  2004-05-28       Impact factor: 4.759

10.  Cytochrome P-450-dependent oxidation of lanosterol in cholesterol biosynthesis. Microsomal electron transport and C-32 demethylation.

Authors:  J M Trzaskos; W D Bowen; A Shafiee; R T Fischer; J L Gaylor
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.